Opinion/decision on a Paediatric investigation plan (PIP): Enhertu, trastuzumab deruxtecan, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant an

Submitted by Anonymous (not verified) on 8 December 2025 - 16:14

Opinion/decision on a Paediatric investigation plan (PIP): Enhertu, trastuzumab deruxtecan, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0397/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness